X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32) 32
index medicus (31) 31
female (20) 20
male (19) 19
hematology (15) 15
lymphomas (14) 14
middle aged (14) 14
oncology (13) 13
adult (12) 12
gene expression (12) 12
cancer (10) 10
genetic aspects (10) 10
hemic and lymphatic diseases (10) 10
aged (9) 9
genes (9) 9
analysis (8) 8
b-cell lymphoma (8) 8
lymphoma (8) 8
mutation (8) 8
pathology (8) 8
aged, 80 and over (7) 7
cell line, tumor (7) 7
child, preschool (7) 7
adolescent (6) 6
chemotherapy (6) 6
child (6) 6
expression (6) 6
gene-expression (6) 6
lymphocytes b (6) 6
mantle cell lymphoma (6) 6
prognosis (6) 6
tumors (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
apoptosis (5) 5
article (5) 5
burkitt lymphoma - genetics (5) 5
c-myc (5) 5
children (5) 5
clinical trials (5) 5
differentiation (5) 5
genetic research (5) 5
immunohistochemistry (5) 5
leukemia (5) 5
lymphoma, b-cell - genetics (5) 5
lymphoma, mantle-cell - genetics (5) 5
pathogenesis (5) 5
translocation, genetic (5) 5
animals (4) 4
burkitt's lymphoma (4) 4
cell biology (4) 4
deoxyribonucleic acid--dna (4) 4
follicular lymphoma (4) 4
gene expression regulation, neoplastic (4) 4
genomes (4) 4
genomics (4) 4
health aspects (4) 4
hodgkin disease - pathology (4) 4
immune system diseases (4) 4
immunoglobulin heavy chains - genetics (4) 4
lymphocytes t (4) 4
lymphoma, b-cell - metabolism (4) 4
mice (4) 4
molecular sequence data (4) 4
translocation (4) 4
treatment outcome (4) 4
young adult (4) 4
activation (3) 3
b-cell lymphomas (3) 3
b-cells (3) 3
base sequence (3) 3
burkitt lymphoma - diagnosis (3) 3
burkitt lymphoma - pathology (3) 3
cell lines (3) 3
chronic lymphocytic-leukemia (3) 3
clonal evolution - genetics (3) 3
cohort studies (3) 3
combined modality therapy (3) 3
cyclophosphamide - administration & dosage (3) 3
cytogenetics (3) 3
diagnosis (3) 3
diagnosis, differential (3) 3
diffuse large b-cell lymphoma (3) 3
disease (3) 3
dna methylation (3) 3
follow-up studies (3) 3
gene mutations (3) 3
genes, myc (3) 3
genomic aberrations (3) 3
immunoglobulins (3) 3
immunotherapy (3) 3
kinases (3) 3
lymphocytes (3) 3
lymphoma, follicular - genetics (3) 3
lymphoma, large b-cell, diffuse - genetics (3) 3
macrophages (3) 3
medical prognosis (3) 3
methylation (3) 3
multidisciplinary sciences (3) 3
mutations (3) 3
myc (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Seminars in Diagnostic Pathology, ISSN 0740-2570, 2011, Volume 28, Issue 2, pp. 146 - 160
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 7, pp. 1434 - 1439
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 928 - 942
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1111 - 1122
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2013, Volume 110, Issue 45, pp. 18250 - 18255
Journal Article
Haematologica, ISSN 0390-6078, 04/2008, Volume 93, Issue 4, pp. 551 - 559
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1680 - 1687
A high proportion of patients with relapsed classical Hodgkin's lymphoma achieve a response with the antibody-drug conjugate brentuximab vedotin, and the drug... 
ABVD | COPP | ONCOLOGY | DISEASE | BEACOPP | REGIMEN | OPEN-LABEL | HD15 TRIALS | CHEMOTHERAPY | STANDARD | Procarbazine - administration & dosage | Predictive Value of Tests | Confidence Intervals | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Hodgkin Disease - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Immunoconjugates - administration & dosage | Dose-Response Relationship, Drug | Neoplasm Invasiveness - pathology | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Immunoconjugates - adverse effects | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Kaplan-Meier Estimate | Etoposide - administration & dosage | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Disease-Free Survival | Procarbazine - adverse effects | Survival Analysis | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Germany | Clinical trials | Care and treatment | Product development | Lymphomas | Biological products | Analysis
Journal Article
Journal Article